Literature DB >> 10624849

Results of hypofractionated stereotactic re-irradiation on 13 locally recurrent nasopharyngeal carcinomas.

R Orecchia1, M G Redda, R Ragona, D Nassisi, B Jereczek-Fossa, S Zurrida, M Bussi, G Succo, G Sannazzari.   

Abstract

Thirteen patients with locally recurrent, previously-irradiated nasopharyngeal carcinoma were treated with linac-based hypofractionated stereotactic radiotherapy (24 Gy in two or four fractions). One- and 3-year overall survival were 54 and 31%. Three patients were free of disease at 30, 34 and 65 months. No severe acute or late complications were seen.

Entities:  

Mesh：

Year:  1999        PMID： 10624849     DOI： 10.1016/s0167-8140(99)00130-9

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  5 in total

1.  Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma.

Authors:  Victor H F Lee; Dora L W Kwong; To-Wai Leung; Sherry C Y Ng; Ka-On Lam; Chi-Chung Tong; Chun-Kin Sze
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-13       Impact factor: 2.503

2.  Re-irradiation with curative intent in patients with squamous cell carcinoma of the head and neck: a national survey of usual practice on behalf of the Italian Association of Radiation Oncology (AIRO).

Authors:  Marta Maddalo; Pierluigi Bonomo; Liliana Belgioia; Almalina Bacigalupo; Vittorio Donato; Daniela Alterio; Ester Orlandi; Angela Argenone; Anna Merlotti; Daniela Musio; Marianna Trignani; Stefano Ursino; Stefano Arcangeli; Carlo Furlan; Mattia Falchetto Osti
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-26       Impact factor: 2.503

3.  Stereotactic ablative radiosurgery for locally advanced or recurrent skull base malignancies with prior external beam radiation therapy.

Authors:  Karen M Xu; Kimmen Quan; David A Clump; Robert L Ferris; Dwight E Heron
Journal:  Front Oncol       Date:  2015-03-17       Impact factor: 6.244

4.  Patient-Derived Nasopharyngeal Cancer Organoids for Disease Modeling and Radiation Dose Optimization.

Authors:  Sasidharan Swarnalatha Lucky; Martin Law; Ming Hong Lui; Jamie Mong; Junli Shi; Sidney Yu; Do Kun Yoon; Shih Kien Djeng; Jiguang Wang; Chwee Ming Lim; Min Han Tan
Journal:  Front Oncol       Date:  2021-02-23       Impact factor: 6.244

5.  Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis.

Authors:  Daniel T T Chua; Shao-Xiong Wu; Victor Lee; Janice Tsang
Journal:  Head Neck Oncol       Date:  2009-05-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.